Prognostic Value of Serum Soluble Programmed Death-Ligand 1 and Dynamics During Chemotherapy in Advanced Gastric Cancer Patients

PURPOSE: The soluble form programmed death-ligand 1 (sPDL1) has immunosuppressive properties and is being studied as a candidate biomarker for immuno-oncology drug development. We measured the serum sPDL1 at pre-and post-chemotherapy and evaluated its prognostic implication and dynamics during chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Woochan, Bang, Ju-Hee, Nam, Ah-Rong, Jin, Mei Hua, Seo, Hyerim, Kim, Jae-Min, Oh, Kyoung Seok, Kim, Tae-Yong, Oh, Do-Youn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812012/
https://www.ncbi.nlm.nih.gov/pubmed/33070562
http://dx.doi.org/10.4143/crt.2020.497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812012/
https://www.ncbi.nlm.nih.gov/pubmed/33070562
http://dx.doi.org/10.4143/crt.2020.497

Ejemplares similares